U.S. markets closed

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.440.00 (0.00%)
At close: 4:00PM EDT
8.44 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
12,862
8,823
0
0
0
Operating Expense
82,720
80,434
84,217
33,498
22,993
Operating Income
-69,858
-71,611
-84,217
-33,498
-22,993
Net Non Operating Interest Income Expense
-
-
1,511
518
1
Other Income Expense
492
792
29
392
28
Pretax Income
-69,366
-70,819
-82,677
-32,588
-22,964
Net Income Common Stockholders
-69,366
-70,819
-89,805
-32,588
-25,371
Diluted NI Available to Com Stockholders
-69,366
-70,819
-89,805
-32,588
-25,371
Basic EPS
-
-2.79
-8.13
-2.98
-2.32
Diluted EPS
-
-2.79
-8.13
-2.98
-2.32
Basic Average Shares
-
25,354
11,046
10,951
10,951
Diluted Average Shares
-
25,354
11,046
10,951
10,951
Total Operating Income as Reported
-69,858
-71,611
-84,217
-33,498
-22,993
Total Expenses
82,720
80,434
84,217
33,498
22,993
Net Income from Continuing & Discontinued Operation
-69,366
-70,819
-82,677
-32,588
-22,964
Normalized Income
-69,366
-70,819
-82,677
-32,588
-22,964
Net Interest Income
-
-
1,511
518
1
EBIT
-69,858
-71,611
-84,217
-33,498
-22,993
EBITDA
-67,415
-
-
-
-
Reconciled Depreciation
2,443
2,379
2,053
1,345
715
Net Income from Continuing Operation Net Minority Interest
-69,366
-70,819
-82,677
-32,588
-22,964
Normalized EBITDA
-67,415
-69,232
-82,164
-32,153
-22,278
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0